Compare OLMA & UEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OLMA | UEC |
|---|---|---|
| Founded | 2006 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 949.3M | 5.0B |
| IPO Year | 2020 | 2008 |
| Metric | OLMA | UEC |
|---|---|---|
| Price | $6.58 | $7.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 11 |
| Target Price | ★ $36.50 | $16.03 |
| AVG Volume (30 Days) | 1.2M | ★ 9.5M |
| Earning Date | 11-09-2026 | 09-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $37,250,000.00 |
| Revenue This Year | N/A | $70.84 |
| Revenue Next Year | N/A | $178.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.61 | $7.27 |
| 52 Week High | $36.26 | $20.34 |
| Indicator | OLMA | UEC |
|---|---|---|
| Relative Strength Index (RSI) | 17.35 | 31.73 |
| Support Level | N/A | N/A |
| Resistance Level | $11.27 | $10.31 |
| Average True Range (ATR) | 0.39 | 0.49 |
| MACD | -0.10 | -0.11 |
| Stochastic Oscillator | 2.97 | 18.60 |
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Uranium Energy Corp is engaged in uranium mining and related activities, including exploration, permitting, pre-extraction, extraction, recovery, and processing. The Company undertakes conventional and ISR uranium extraction and recovery and the exploration, permitting, and evaluation of uranium properties in the United States, Canada, and the Republic of Paraguay. Its principal projects are located in Wyoming and Texas in the United States and Saskatchewan, Canada. The Company operates three hub-and-spoke platforms in South Texas and Wyoming, anchored by licensed CPPs and served by ISR and conventional uranium projects. Its operating segments consist of uranium exploration and mining activities in Wyoming, Texas, Saskatchewan, and others, with Wyoming generating maximum revenue.